Cargando…

High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan

INTRODUCTION: HIV and HCV risk behaviors among injection drug users (IDUs) in two urban areas in Pakistan were identified. METHODS: From May to June 2003, 351 IDUs recruited in harm-reduction drop-in centers operated by a national non-governmental organization in Lahore (Punjab province) and Quetta...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Irene, ul-Hasan, Salman, Galai, Noya, Thomas, David L, Zafar, Tariq, Ahmed, Mohammad A, Strathdee, Steffanie A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1564387/
https://www.ncbi.nlm.nih.gov/pubmed/16914042
http://dx.doi.org/10.1186/1477-7517-3-26
_version_ 1782129561170870272
author Kuo, Irene
ul-Hasan, Salman
Galai, Noya
Thomas, David L
Zafar, Tariq
Ahmed, Mohammad A
Strathdee, Steffanie A
author_facet Kuo, Irene
ul-Hasan, Salman
Galai, Noya
Thomas, David L
Zafar, Tariq
Ahmed, Mohammad A
Strathdee, Steffanie A
author_sort Kuo, Irene
collection PubMed
description INTRODUCTION: HIV and HCV risk behaviors among injection drug users (IDUs) in two urban areas in Pakistan were identified. METHODS: From May to June 2003, 351 IDUs recruited in harm-reduction drop-in centers operated by a national non-governmental organization in Lahore (Punjab province) and Quetta (Balochistan province) completed an interviewer-administered survey and were tested for HIV and HCV. Multivariable logistic regression identified correlates of seropositivity, stratifying by site. All study participants provided written, informed consent. RESULTS: All but two were male; median age was 35 and <50% had any formal education. None were HIV-positive; HCV seroprevalence was 88%. HIV awareness was relatively high, but HCV awareness was low (19%). Injection behaviors and percutaneous exposures such as drawing blood into a syringe while injecting ('jerking'), longer duration of injection, and receiving a street barber shave were significantly associated with HCV seropositivity. DISCUSSION: Despite no HIV cases, overall HCV prevalence was very high, signaling the potential for a future HIV epidemic among IDUs across Pakistan. Programs to increase needle exchange, drug treatment and HIV and HCV awareness should be implemented immediately.
format Text
id pubmed-1564387
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-15643872006-09-14 High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan Kuo, Irene ul-Hasan, Salman Galai, Noya Thomas, David L Zafar, Tariq Ahmed, Mohammad A Strathdee, Steffanie A Harm Reduct J Research INTRODUCTION: HIV and HCV risk behaviors among injection drug users (IDUs) in two urban areas in Pakistan were identified. METHODS: From May to June 2003, 351 IDUs recruited in harm-reduction drop-in centers operated by a national non-governmental organization in Lahore (Punjab province) and Quetta (Balochistan province) completed an interviewer-administered survey and were tested for HIV and HCV. Multivariable logistic regression identified correlates of seropositivity, stratifying by site. All study participants provided written, informed consent. RESULTS: All but two were male; median age was 35 and <50% had any formal education. None were HIV-positive; HCV seroprevalence was 88%. HIV awareness was relatively high, but HCV awareness was low (19%). Injection behaviors and percutaneous exposures such as drawing blood into a syringe while injecting ('jerking'), longer duration of injection, and receiving a street barber shave were significantly associated with HCV seropositivity. DISCUSSION: Despite no HIV cases, overall HCV prevalence was very high, signaling the potential for a future HIV epidemic among IDUs across Pakistan. Programs to increase needle exchange, drug treatment and HIV and HCV awareness should be implemented immediately. BioMed Central 2006-08-16 /pmc/articles/PMC1564387/ /pubmed/16914042 http://dx.doi.org/10.1186/1477-7517-3-26 Text en Copyright © 2006 Kuo et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Kuo, Irene
ul-Hasan, Salman
Galai, Noya
Thomas, David L
Zafar, Tariq
Ahmed, Mohammad A
Strathdee, Steffanie A
High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan
title High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan
title_full High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan
title_fullStr High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan
title_full_unstemmed High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan
title_short High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan
title_sort high hcv seroprevalence and hiv drug use risk behaviors among injection drug users in pakistan
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1564387/
https://www.ncbi.nlm.nih.gov/pubmed/16914042
http://dx.doi.org/10.1186/1477-7517-3-26
work_keys_str_mv AT kuoirene highhcvseroprevalenceandhivdruguseriskbehaviorsamonginjectiondrugusersinpakistan
AT ulhasansalman highhcvseroprevalenceandhivdruguseriskbehaviorsamonginjectiondrugusersinpakistan
AT galainoya highhcvseroprevalenceandhivdruguseriskbehaviorsamonginjectiondrugusersinpakistan
AT thomasdavidl highhcvseroprevalenceandhivdruguseriskbehaviorsamonginjectiondrugusersinpakistan
AT zafartariq highhcvseroprevalenceandhivdruguseriskbehaviorsamonginjectiondrugusersinpakistan
AT ahmedmohammada highhcvseroprevalenceandhivdruguseriskbehaviorsamonginjectiondrugusersinpakistan
AT strathdeesteffaniea highhcvseroprevalenceandhivdruguseriskbehaviorsamonginjectiondrugusersinpakistan